Q32 Bio share price logo

Q32 Bio

NASDAQ: QTTB

Small Cap

$8.73

+0.02

(+0.29%)

Live

as on

Q32 Bio Stock Performance

as on November 4, 2026 at 4:56 am IST

  • Day's Low

    Day's High

    $8.68
    $9.03
    downward going graph

    0.57%

    Downside

    3.44%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.91
    $23.57
    downward going graph

    78.18%

    Downside

    169.99%

    Upside

    downward going graph

Q32 Bio share price movements today

Previous Close
$8.71
Open
$8.68
Volume
152.4K
Market Cap
$265.2M
Day's Low - High
$8.68 - $9.03
52 Week Low - High
$1.91 - $23.57

Q32 Bio Historical Returns

1 Month Return
+ 5.83 %
3 Month Return
-42.57 %
1 Year Return
+ 238.91 %
3 Year Return
0 %
5 Year Return
0 %

Q32 Bio Stock Fundamentals & Key Indicators

Check Q32 Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$265.2M

EPS (TTM)

2.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.19

Industry PE ratio

-7.24

PEG Ratio

0.01

EBITDA

34.5M

Revenue (TTM)

53.7M

Profit Margin

99.84%

Return On Equity TTM

76.88%

Q32 Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Q32 Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Q32 Bio image
Q32 Bio
StrongBuy$265.2MNA3.1999.84%0.00%
Moderna image
Moderna
Neutral$88.5B-36.16%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Q32 Bio Stock including INR - Dollar returns

The Q32 Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Q32 Bio investment value today

Current value as on today

₹3,62,724

Returns

₹2,62,724

(+262.72%)

Returns from Q32 Bio Stock

₹2,39,689 (+239.69%)

Dollar Impact

₹23,035 (+23.03%)

Analyst Recommendation on Q32 Bio Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Q32 Bio. Average target price of $39.67

Q32 Bio Share Price Target

Get share price movements and forecasts by analysts on Q32 Bio.

What analysts predicted

77.99%UPSIDE

Target Price

$39.67

Current Price

$8.73

Analyzed by

5 Analysts

High

$59

Target

$39.67

Low

$29

Q32 Bio target price $39.67, a slight upside of 77.99% compared to current price of $8.73. According to 5 analysts rating.

Indian Investors' Interest in Q32 Bio Stock

Search interest for Q32 Bio Stock has decreased by -1% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-1% versus previous 30 day period

Q32 Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
53
-
-
Gross Profit
-
-
-
-
-
-
-
53
-
0
Operating Income
-14
-17
-18
-14
-12
-9
-7
45
-7
-9
EBITDA
-14
-17
-17
6
-12
-9
-6
58
-7
-8
Interest Expense
-
-
0
-
0
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%

Q32 Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
5
1
2
-
6
-6
-
53
Gross Profit
0
5
1
-
-
6
-6
-
53
Operating Income
-29
-59
-109
-130
-36
-39
-48
-66
16
EBITDA
-29
-58
-97
-121
-27
-38
-47
-44
31
Interest Expense
-
-
-
-
-
-
-
1
1
Depreciation
0
1
6
8
9
0
0
0
0
Income Before Tax
-29
-55
-103
-128
-37
-42
-53
-47
29
Income Tax Expense
0
-
-
-
0
0
0
0
-
Net Income
-29
-55
-103
-128
-37
-42
-53
-47
29
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
71.91%
100.00%
100.00%
0.00%
100.00%

Q32 Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Operating Cash Flow
-14
-22
-19
-11
-12
-10
-4
-6
-6
-3
Investing Cash Flow
0
9
9
0
-
-
-
7
-
-
Financing Cash Flow
99
-5
0
0
-
-
-1
-1
8
58
Change in Cash
84
-17
-8
-11
-12
-10
-5
0
2
55

Q32 Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-55
-103
-128
-95
-42
-53
-47
29
Operating Cash Flow
6
-42
-91
-94
-109
-10
-18
-67
-33
Investing Cash Flow
-81
-121
-51
204
-50
-2
0
19
7
Financing Cash Flow
115
150
158
53
52
30
0
95
-3
Change in Cash
40
-13
15
163
-109
16
-8
47
-29

Global Institutional Holdings in Q32 Bio

Check out the Institutions with significant holdings in Q32 Bio.

Funds
Holdings
Peter Kolchinsky
7.84%
Vanguard
3.32%
Orbimed Advisors Llc
2.10%
Diyong Xu
2.10%
Avantis
2.04%
See all

Q32 Bio News & Key Events

  • img

    Today's Timeline - 30 September

    Wed, 06:50 PM

    -

    Q32 Bio announces significant results from Part B of the SIGNAL-AA Phase 2a trial for bempikibart in severe alopecia areata.

Insights on Q32 Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, QTTB stock has moved up by 72.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -14.66M → 53.73M (in $), with an average increase of 127.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 547.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 57.73M → -8.94M (in $), with an average decrease of 65.4% per quarter

About Q32 Bio

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.
OrganisationQ32 Bio
Headquarters830 Winter Street, Waltham, MA, 02451, US
IndustryBiotechnology
CEOJodie Pope Morrison

Key Management of Q32 Bio

Name

Title

Ms. Maria Marzilli M.P.H.

Chief Business Officer

Dr. José M. Trevejo M.D., Ph.D.

Chief Medical Officer

Dr. Elham Hershberger Pharm.D.

Chief Development Officer

Ms. Jodie Pope Morrison

CEO & Director

Mr. Lee H. Kalowski M.B.A.

CFO & President

Dr. Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Mr. David Appugliese J.D.

Senior VP & Head of People

FAQs

What is Q32 Bio share price today?

Q32 Bio share price today is $8.73 as on . Q32 Bio share today touched a day high of $9.03 and a low of $8.68.

What is the 52 week high and 52 week low for Q32 Bio share?

Q32 Bio share touched a 52 week high of $23.57 on and a 52 week low of $1.91 on . Q32 Bio stock price today i.e. is trending at $8.73,which is 62.96% down from its 52 week high and 358.27% up from its 52 week low.

What is Q32 Bio's market capitalisation today?

Q32 Bio market capitalisation is $0.00T as on .

How to invest in Q32 Bio Stock (QTTB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Q32 Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Q32 Bio Stock (QTTB) from India?

Indian investors can start investing in Q32 Bio (QTTB) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Q32 Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Q32 Bio share’s latest price of $8.73 as on November 3, 2026 at 11:26 pm IST, you will get 1.1455 shares of Q32 Bio. Learn more about fractional shares .